公吿精選︱柳工:2024年度淨利潤預增45%-70%;卓創資訊:與幻方量化尚未建立業務合作關係

【熱點】
森霸傳感(300701.SZ):實際控制人、董事長被留置
卓創資訊(301299.SZ):與幻方量化尚未建立業務合作關係
海航控股(600221.SH):計劃處置9架B787-8飛機
【項目投資】
上海醫藥(601607.SH):擬出資10億元參設併購基金
東富龍(300171.SZ):擬與專業機構共同投資設立上海生物醫藥併購基金
【合同中標】
雙傑電氣(300444.SZ):中標3.66億元南方電網項目
中鋁國際(601068.SH):2024年新籤合同總額為308.26億元
恒尚節能(603137.SH):2024年度累計新籤項目金額20.84億元,比上年增加5.36%
【業績預吿】
本鋼板材(000761.SZ):2024年度預虧50.2億元
福星股份(000926.SZ):2024年度預虧19.46億元-24.75億元
柳工(000528.SZ):2024年度淨利潤預增45%-70%
聖邦股份(300661.SZ):2024年度淨利潤預增60%-90%
商絡電子(300975.SZ):預計2024年淨利潤同比增長85.34%-126.52%
【股權收購】
致尚科技(301486.SZ):擬將福可喜瑪53%股權轉讓給泓淇光電基金
羚鋭製藥(600285.SH):擬收購銀谷製藥90%股權
畢得醫藥(688073.SH):擬收購維播投資的部分股權
華懋科技(603306.SH):擬8500萬元受讓深圳富創10%股權
【回購】
寶蘭德(688058.SH):累計回購3.01%公司股份
太龍藥業(600222.SH):已實際回購1.12%公司股份
達瑞電子(300976.SZ):累計回購1.08%股份 回購實施期限屆滿
【增減持】
南芯科技(688484.SH):順為科技及其一致行動人累計減持1.7519%公司股份
仙樂健康(300791.SZ):姚壯民累計增持14.85萬股
【其他】
實達集團(600734.SH):擬籌劃重大資產重組
山東玻纖(605006.SH):簽訂戰略合作框架協議
益客食品(301116.SZ):與山東廣明生物簽署戰略合作協議
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.